{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:00:05Z","timestamp":1789736405766,"version":"4.0.1"},"reference-count":0,"publisher":"Physicians Postgraduate Press, Inc","issue":"07","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Psychiatry"],"published-print":{"date-parts":[[2014,7,15]]},"DOI":"10.4088\/jcp.14f09292","type":"journal-article","created":{"date-parts":[[2014,7,28]],"date-time":"2014-07-28T16:12:43Z","timestamp":1406563963000},"page":"e707-e709","source":"Crossref","is-referenced-by-count":8,"title":["Nonsteroidal Anti-inflammatory Drugs and 5-HT<sub>3<\/sub>Serotonin Receptor Antagonists as Innovative Antipsychotic Augmentation Treatments for Schizophrenia"],"prefix":"10.4088","volume":"75","author":[{"given":"Chittaranjan","family":"Andrade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2558","container-title":["The Journal of Clinical Psychiatry"],"original-title":[],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T12:34:16Z","timestamp":1698755656000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.psychiatrist.com\/jcp\/nonsteroidal-anti-inflammatory-drugs-htltsubgtltsubgt"}},"subtitle":["(Practical Psychopharmacology)"],"short-title":[],"issued":{"date-parts":[[2014,7,15]]},"references-count":0,"journal-issue":{"issue":"07","published-print":{"date-parts":[[2014,7,15]]}},"URL":"https:\/\/doi.org\/10.4088\/jcp.14f09292","relation":{},"ISSN":["0160-6689"],"issn-type":[{"value":"0160-6689","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7,15]]}}}